Aliases & Classifications for Polyhydramnios

About this section

Summaries for Polyhydramnios

About this section
Wikipedia:71 Polyhydramnios (polyhydramnion, hydramnios, polyhydramnios) is a medical condition describing an excess... more...

MalaCards based summary: Polyhydramnios is related to gestational diabetes and polyhydramnios, megalencephaly, and symptomatic epilepsy, and has symptoms including false labor and morning sickness. An important gene associated with Polyhydramnios is STRADA (STE20-Related Kinase Adaptor Alpha), and among its related pathways are LKB1 signaling events and Diuretics Pathway, Pharmacodynamics. Affiliated tissues include placenta, lung and bone, and related mouse phenotypes are Decreased substrate adherent cell growth and reproductive system.

Disease Ontology:11 A placenta disease that is characterized by an excess of amniotic fluid in the amniotic sac.

Related Diseases for Polyhydramnios

About this section

Diseases related to Polyhydramnios via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 108)
idRelated DiseaseScoreTop Affiliating Genes
1gestational diabetes28.9AQP1, AQP3, SLC12A1
2polyhydramnios, megalencephaly, and symptomatic epilepsy12.3
3muscular hypertrophy-hepatomegaly-polyhydramnios syndrome11.8
4oligohydramnios11.1
5twin-to-twin transfusion syndrome11.0
6perlman syndrome10.8
7lethal congenital contracture syndrome 710.8
8fetal akinesia syndrome x-linked10.8
9restrictive dermopathy, lethal10.7
10multiple pterygium syndrome, lethal type10.7
11chondrodysplasia, blomstrand type10.7
12nemaline myopathy 1010.7
13fetal akinesia deformation sequence10.7
14bartter syndrome, type 210.7
15lethal congenital contracture syndrome 610.7
16bartter syndrome, type 110.7
17duodenal atresia10.7
18bartter disease type 510.7
19cataract 710.4STK11, STRADA
20intramural coronary arterial course10.3KCNJ1, MAGED2, SLC12A1
21collecting duct carcinoma10.3KCNJ1, SLC12A1
22central nervous system angiosarcoma10.2KCNJ1, SLC12A1
23bestrophinopathy10.0CLCNKB, KCNJ1, SLC12A1
24mucinous tubular and spindle renal cell carcinoma10.0CLCNKB, KCNJ1, SLC12A1
25episodic kinesigenic dyskinesia 210.0CLCNKB, KCNJ1, SLC12A1
26chorioangioma10.0
27mucinous adenocarcinoma10.0AFP, STK11
28cervix erosion9.9AFP, KCNJ1, SLC12A1
29contact dermatitis9.9AFP, FGFR3
30prostate leiomyosarcoma9.9AQP1, AQP3
31gastrointestinal system benign neoplasm9.9AFP, FH
32reflex epilepsy9.9AFP, FGFR3
33myotonic dystrophy9.9
34cervicitis9.8
35teratoma9.8
36congenital mesoblastic nephroma9.8
37prostate cancer, hereditary, x-linked 19.8FGFR3, HSD17B4, STK11
38hydronephrosis9.8
39cerebritis9.8
40congenital diaphragmatic hernia9.8
41ovarian cyst9.8
42hydrops fetalis9.8
43spondylolysis9.7AQP1, SLC12A1
44palmoplantar keratoderma, bothnian type9.7AQP1, AQP3, SLC12A1
45apert syndrome9.7
46costello syndrome9.7
47prader-willi syndrome9.7
48pseudohypoaldosteronism9.7
49omphalocele9.7
50esophagitis9.7

Graphical network of the top 20 diseases related to Polyhydramnios:



Diseases related to polyhydramnios

Symptoms & Phenotypes for Polyhydramnios

About this section

UMLS symptoms related to Polyhydramnios:


false labor, morning sickness

GenomeRNAi Phenotypes related to Polyhydramnios according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00193-A-39.9FGFR3, STK11, STRADA

MGI Mouse Phenotypes related to Polyhydramnios according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053897.7AFP, AQP1, CNTNAP1, FGFR3, HSD17B4, SLC12A1
2MP:00053677.7AQP1, AQP3, CLCNKB, FGFR3, FH, KCNJ1
3MP:00053787.6AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4, KCNJ1
4MP:00053917.3AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4, STK11
5MP:00053867.2AFP, AQP1, AQP3, CNTNAP1, FGFR3, HSD17B4
6MP:00053766.8AFP, AQP1, AQP3, CLCNKB, FGFR3, FH
7MP:00107686.6AFP, AQP1, AQP3, CNTNAP1, FGFR3, FH

Drugs & Therapeutics for Polyhydramnios

About this section

Drugs for Polyhydramnios (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GlyburideapprovedPhase 411110238-21-83488
Synonyms:
1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
AB00051949
AC1L1G1Q
AC1Q44V7
AKOS001487495
Abbenclamide
Adiab
Apo-Glibenclamide
Azuglucon
BIDD:GT0239
BPBio1_000344
BRD-K36927236-001-06-0
BRN 2230085
BSPBio_000312
BSPBio_001351
BSPBio_003053
Bastiverit
Benclamin
Betanase
Betanese 5
Bio-0156
Bio1_000076
Bio1_000565
Bio1_001054
Bio2_000071
Bio2_000551
C07022
C23H28ClN3O5S
CAS-10238-21-8
CBiol_001790
CHEBI:5441
CHEMBL472
CID3488
CPD000058229
Calabren
Cytagon
D00336
D005905
DB01016
Daonil
Debtan
Dia-basan
Diabeta
Diabeta (TN)
Diabiphage
Dibelet
DivK1c_000481
Duraglucon
EINECS 233-570-6
EU-0100499
Euclamin
Euglucan
Euglucon
Euglucon 5
Euglucon N
Euglykon
G 0639
G0639_SIAL
G0639_SIGMA
G2539_SIAL
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Gliben-Puren N
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M
Glibenclamid Riker M.
Glibenclamid-Cophar
Glibenclamid-Ratiopharm
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamide
Glibenclamide (JP15/INN)
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Glibens
Glibesyn
Glibet
Glibetic
Glibil
Gliboral
Glicem
Glidiabet
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Gluco-Tablimen
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
Glyburide
Glyburide (USP)
Glyburide (micronized)
Glyburide [USAN]
 
Glycolande
Glycomin
Glynase
Glynase (TN)
HB 419
HB 420
HB-419
HB-420
HB419
HB420
HMS1361D13
HMS1568P14
HMS1791D13
HMS1922L08
HMS1989D13
HMS2089L06
HMS2093P04
HMS501I03
Hemi-Daonil
Hexaglucon
Humedia
I06-0716
IDI1_000481
IDI1_033821
KBio1_000481
KBio2_000071
KBio2_000730
KBio2_002639
KBio2_003298
KBio2_005207
KBio2_005866
KBio3_000141
KBio3_000142
KBio3_002273
KBioGR_000071
KBioGR_001897
KBioSS_000071
KBioSS_000730
LS-159295
Lederglib
Libanil
Lisaglucon
Lopac-G-0639
Lopac0_000499
MLS000069721
MLS001077262
Malix
Maninil
Med-Glionil
Melix
Micronase
Micronase (TN)
Micronized glyburide
Miglucan
MolPort-000-784-850
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
NCGC00015467-01
NCGC00015467-02
NCGC00015467-06
NCGC00015467-16
NCGC00016689-01
NCGC00023447-02
NCGC00023447-04
NCGC00023447-05
NCGC00023447-06
NCGC00023447-07
NCGC00023447-08
NCGC00023447-09
NCGC00023447-10
NCGC00023447-11
NCGC00023447-12
NINDS_000481
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Oprea1_764617
Orabetic
Pira
Praeciglucon
PresTab
Prestwick0_000316
Prestwick1_000316
Prestwick2_000316
Prestwick3_000316
Prestwick_569
Probes1_000431
Probes2_000378
Prodiabet
Renabetic
S1716_Selleck
SAM002564212
SMR000058229
SPBio_001831
SPBio_002531
SPECTRUM2300229
SR-01000000196-5
STK362992
Semi-Daonil
Semi-Euglucon
Semi-Gliben-Puren N
Semi-daonil
Spectrum2_001816
Spectrum3_001327
Spectrum4_001199
Spectrum5_001631
Spectrum_000250
Sugril
Suraben
Tiabet
Tocris-0911
U 26452
U-26452
UNII-SX6K58TVWC
UPCMLD-DP006
UPCMLD-DP006:001
UR 606
Yuglucon
ZINC00537805
glibenclamide
glyburide
2
MetforminapprovedPhase 41746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
3Hypoglycemic AgentsPhase 45733
4
Betamethasoneapproved, vet_approvedPhase 1, Phase 2183378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Valearate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
 
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
5Hormone AntagonistsPhase 1, Phase 212778
6HormonesPhase 1, Phase 213979
7Respiratory System AgentsPhase 1, Phase 24818
8Betamethasone-17,21-dipropionatePhase 1, Phase 2183
9Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 212767
10glucocorticoidsPhase 1, Phase 24920
11Anti-Inflammatory AgentsPhase 1, Phase 210355
12Anti-Asthmatic AgentsPhase 1, Phase 23369
13Betamethasone benzoatePhase 1, Phase 2183
14Betamethasone sodium phosphatePhase 1, Phase 2183
15Betamethasone ValeratePhase 1, Phase 21832152-44-5
16
Insulin Detemirapproved196169148-63-45311023
Synonyms:
Detemir
 
Insulin detemir recombinant
Insulin,detemir,human
17
Zincapproved22317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
18
Cholecalciferolapproved, nutraceutical85167-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
19
Ergocalciferolapproved, nutraceutical123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
20vitamin d1653
21Vitamins5095
22Trace Elements5802
23Calcium, Dietary5525
24Micronutrients5802
25Ergocalciferols1232
26Bone Density Conservation Agents3266
27Insulin, Short-Acting90
28Isophane Insulin, Human151
29Insulin, Long-Acting358
30Isophane insulin, beef151
31Insulin, Isophane252
32Insulin, Globin Zinc4523
33insulin4524
34Pharmaceutical Solutions7793
35Vitamin D2Nutraceutical1232
36CalciferolNutraceutical1334

Interventional clinical trials:

(show all 11)
idNameStatusNCT IDPhase
1A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes MellitusCompletedNCT01563120Phase 4
2Syringe or Continuous Amnioreduction for Symptomatic Polyhydramnios. A Prospective Randomized Study.CompletedNCT00236340Phase 3
3Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary HypoplasiaRecruitingNCT01240057Phase 2, Phase 3
4Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)TerminatedNCT00670956Phase 1, Phase 2
5Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) PathologyUnknown statusNCT00687752
6Vitamin D Treatment and Hypocalcemic Pregnant WomenUnknown statusNCT02021864
7Studying Fetal Breathing PatternsCompletedNCT00066976
8Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous PregnancyCompletedNCT01375439
9Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in PregnancyCompletedNCT01837680
10Chewing Gums to Stimulate Intestinal Motility After Cesarean SectionRecruitingNCT02386748
11The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal AnomaliesNot yet recruitingNCT02732717

Search NIH Clinical Center for Polyhydramnios


Cochrane evidence based reviews: polyhydramnios

Genetic Tests for Polyhydramnios

About this section

Genetic tests related to Polyhydramnios:

id Genetic test Affiliating Genes
1 Polyhydramnios27

Anatomical Context for Polyhydramnios

About this section

MalaCards organs/tissues related to Polyhydramnios:

36
Placenta, Lung, Bone, Kidney, Brain, Heart, Fetal lung

Publications for Polyhydramnios

About this section

Articles related to Polyhydramnios:

(show top 50)    (show all 324)
idTitleAuthorsYear
1
Prenatal drainage of fetal urinoma with polyhydramnios: a case report and literature review. (28076981)
2017
2
Idiopathic polyhydramnios at term and pregnancy outcomes: a multicenter observational study. (27625160)
2016
3
EP21.17: Amnioreduction procedure for singleton pregnancies complicated by polyhydramnios causing maternal discomfort. (27647433)
2016
4
Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress. (26948899)
2016
5
Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations. (27120771)
2016
6
Foetal biometry in polyhydramnios: Does femur length fall behind? (26467094)
2016
7
QUESTION 1: Should the passage of a nasogastric tube be universal to all babies born to mothers with polyhydramnios or targeted to those with additional findings on ultrasound? (27540183)
2016
8
Rapid Resolution of Polyhydramnios Foretells Circulatory Collapse for the Donor Twin in Feto-Fetal Transfusion Syndrome. (26932285)
2016
9
Polyhydramnios and cerebellar atrophy: a prenatal presentation of mitochondrial encephalomyopathy caused by mutations in the FBXL4 gene. (27099744)
2016
10
Transient antenatal Bartter's Syndrome and X-linked polyhydramnios: insights from theA genetics of a rare condition. (27633862)
2016
11
Intrapartum, postpartum characteristics and early neonatal outcomes of idiopathic polyhydramnios. (26926000)
2016
12
Molecular cytogenetic characterization of inv dup del(8p) in a fetus associated with ventriculomegaly, hypoplastic left heart, polyhydramnios and intestinal obstruction. (27343326)
2016
13
Polyhydramnios in isolated oral cleft pregnancies: incidence and outcome in a retrospective study. (27943390)
2016
14
Variable genetic penetrance of myotonic dystrophy following the diagnosis of idiopathic polyhydramnios. (27039051)
2016
15
Polyhydramnios in Lrp4 knockout mice with bilateral kidney agenesis: Defects in the pathways of amniotic fluid clearance. (26847765)
2016
16
A Case of the TOF with APV Complicated with Polyhydramnios and Severe Bronchomalacia. (27579200)
2016
17
Idiopathic polyhydramnios: persistence across gestation and impact on pregnancy outcomes. (26937648)
2016
18
Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE). (27170158)
2016
19
Fetal hypothyroidism induced by maternal anti-TSH receptor blocking antibodies and complicated by polyhydramnios despite the absence of goiter. Treatment by intra-amniotic injections of levothyroxine. (27919402)
2016
20
Outcomes From Polyhydramnios With Normal Ultrasound. (26755694)
2016
21
Idiopathic Polyhydramnios: Severity and Perinatal Morbidity. (26862725)
2016
22
Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios. (26970557)
2016
23
Mode of delivery among women admitted with polyhydramnios. (28019126)
2016
24
Can the Myocardial Performance Index Be Used as a New Predictive Factor for a Poor Prognosis in Fetuses With Idiopathic Polyhydramnios? (27821651)
2016
25
Hyperechogenic kidneys and polyhydramnios associated with HNF1B gene mutation. (27286685)
2016
26
Prenatal ultrasound factors and genetic disorders in pregnancies complicated by polyhydramnios. (27247190)
2016
27
Pregnancy after oocyte donation in 45, X Turner syndrome women, complicated by gestational diabetes and polyhydramnios. Case report and mini-review of literature. (26942946)
2016
28
Prenatal Diagnosis and Pregnancy Outcome Analysis of Polyhydramnios. (26720631)
2016
29
Questions about and speculations on the incidence of idiopathic polyhydramnios by fetal gender. (25786637)
2015
30
Polyhydramnios associated with Prader-Willi syndrome. (26271012)
2015
31
Polyhydramnios associated with Prader-Willi syndrome. (26291428)
2015
32
Reply to "Questions about and speculations on the incidence of idiopathic polyhydramnios by fetal gender". (25786638)
2015
33
Decreased umbilical orexin-A level is associated with idiopathic polyhydramnios. (25494826)
2015
34
Acute polyhydramnios after maternal status epilepticus. (26331018)
2015
35
Amniotic fluid biochemistry in isolated polyhydramnios: a series of 464 cases. (26426702)
2015
36
Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome. (25751210)
2015
37
Perinatal Outcome in Idiopathic Polyhydramnios. (26405400)
2015
38
Decreased placental thickness and impaired Doppler indices in idiopathic polyhydramnios: a prospective case-control study. (24874560)
2014
39
Midtrimester isolated polyhydramnios in monochorionic diamniotic multiple gestations. (24858201)
2014
40
Etiology and perinatal outcome of polyhydramnios. (24729436)
2014
41
Idiopathic polyhydramnios and fetal gender. (25288271)
2014
42
Ovine fetal swallowing responses to polyhydramnios. (24760530)
2014
43
Polyhydramnios in the sac of the parasitic twin: atypical manifestation of twin reversed arterial perfusion sequence. (25510847)
2014
44
Placental tumor (chorioangioma) as a cause of polyhydramnios: a case report. (25429242)
2014
45
Predictive value of second and third trimester fetal renal artery Doppler indices in idiopathic oligohydramnios and polyhydramnios in low-risk pregnancies: A longitudinal study. (25363086)
2014
46
Amnioreduction in the management of polyhydramnios complicating singleton pregnancies. (24881825)
2014
47
Fetal swallowing as a protective mechanism against oligohydramnios and polyhydramnios in late gestation sheep. (22872543)
2013
48
Polyhydramnios as a predictor of adverse pregnancy outcomes. (23573383)
2013
49
Polyhydramnios and adverse perinatal outcome - what is the actual cutoff? (24111654)
2013
50
Twin-twin transfusion syndrome presenting as polyhydramnios in both fetuses secondary to spontaneous microseptostomy. (24147241)
2013

Variations for Polyhydramnios

About this section

Expression for genes affiliated with Polyhydramnios

About this section
Search GEO for disease gene expression data for Polyhydramnios.

Pathways for genes affiliated with Polyhydramnios

About this section

Pathways related to Polyhydramnios according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8STK11, STRADA
29.6CLCNKB, KCNJ1, SLC12A1

GO Terms for genes affiliated with Polyhydramnios

About this section

Biological processes related to Polyhydramnios according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1activation of protein kinase activityGO:003214710.6STK11, STRADA
2positive regulation of protein serine/threonine kinase activityGO:007190210.6STK11, STRADA
3excretionGO:000758810.3AQP3, CLCNKB, KCNJ1
4ion transmembrane transportGO:003422010.3AQP3, CLCNKB, SLC12A1
5cellular water homeostasisGO:000999210.3AQP1, AQP3
6glycerol transportGO:001579310.3AQP1, AQP3
7odontogenesisGO:004247610.3AQP1, AQP3
8renal water homeostasisGO:000309110.2AQP1, AQP3
9potassium ion transportGO:000681310.0AQP1, KCNJ1, SLC12A1
10water transportGO:00068339.5AQP1, AQP3
11transportGO:00068109.5AFP, AQP3, CLCNKB, SLC12A1

Molecular functions related to Polyhydramnios according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein kinase activator activityGO:003029510.2STK11, STRADA
2glycerol channel activityGO:00152549.9AQP1, AQP3
3water channel activityGO:00152509.5AQP1, AQP3

Sources for Polyhydramnios

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet